Aminoglycoside-Induced Cochleotoxicity: A Review

Area of Science:

• Pharmacology
• Toxicology
• Otolaryngology

Background:

• Aminoglycoside antibiotics are essential for life-saving treatments of severe bacterial infections.
• Despite clinical use for over 70 years, the mechanisms of aminoglycoside-induced kidney and inner ear toxicity remain incompletely understood.
• Ototoxicity and nephrotoxicity are significant concerns limiting aminoglycoside use.

Purpose of the Study:

• To elucidate the mechanisms of aminoglycoside-induced ototoxicity.
• To identify factors that exacerbate aminoglycoside toxicity.
• To discuss potential clinical strategies for otoprotection against aminoglycoside-induced hearing loss.

Main Methods:

• Review of existing literature on aminoglycoside pharmacology and toxicology.
• Analysis of drug trafficking, sensory cell uptake, and intracellular pathway disruption.
• Identification of potentiating factors like noise exposure and co-administered drugs.

Main Results:

• Aminoglycoside toxicity involves drug transport across barriers, uptake by sensory cells, and disruption of intracellular processes.
• Risk factors include high-dose or prolonged exposure, concurrent use of loop diuretics or glycopeptides, and high ambient sound levels.
• Systemic inflammation from severe infections potentiates ototoxicity.

Conclusions:

• Understanding aminoglycoside toxicity mechanisms is crucial for developing otoprotective strategies.
• Clinical approaches may involve reducing drug uptake into cochlear/vestibular cells or mitigating intracellular damage.
• Further research is needed to translate these findings into effective clinical otoprotection.